Resistance pattern of anaerobic bacteria isolated in a general hospital during a two-year period

Size: px
Start display at page:

Download "Resistance pattern of anaerobic bacteria isolated in a general hospital during a two-year period"

Transcription

1 Journal of Antimicrobial Chemotherapy (9), Supp. D, 9 6 Resistance pattern of anaerobic bacteria isolated in a general hospital during a two-year period J. F. Acar, F. W. Goldstein, M. D. Kitzis and M. T. Eyquem Hopital Saint Joseph, Universite Pierre & Marie Curie, 7 Rue Pierre Larousse, 767 Paris Cedex, France Summary During a -year period, 77 anaerobic bacteria were isolated from clinical specimens. Bacteroides sp. were the most common bacteria (9%) followed by Peptococcus and Peptostreptococcus (%) and Clostridium (6%). On the basis of disc tests, Bacteroides sp. have been found resistant to ampicillin (6%) tetracycline (6%), clindamycin (0%), chloramphenicol (6-%) and metronidazole (%). Some strains had joint resistance to several useful antibiotics. In some cases, resistance was confirmed by MIC determinations. Introduction Anaerobic bacteria are isolated from infected patients with increasing frequency, even in unspecialized laboratories. It has been generally assumed, since anaerobic infections are frequently polymicrobic and cultures require relatively long periods of time for growth and identification, that the routine susceptibility testing of isolates is unpractical. However, the in-vitro antimicrobial susceptibility pattern of anaerobic bacteria seems to undergo gradual change (Kislak, 97; Phillips, 97; Chow, Patten & Guze 97; Sutter & Finegold, 976; Appelbaum & Chatterton, 97; Dubois, Pechere & Turgeon 97; Percival & Cumberland 97; Sutter et al. 97; Brown & Waati, 90; King et al., 90; Tytgat, 90; Soussy, Thibault & Duval, 9). Periodic surveys to monitor changing patterns of resistance and to determine the possible effectiveness of new agents are thus very desirable. Such surveys can be made by centres having the capability to receive, to store and to test a large number of strains sent from different hospitals in a country. The results might help in the empirical selection of the right antibiotic at the bedside of the patient. We have developed in an unspecialized routine laboratory, a simple disc method for rapid estimation of the antibiotic susceptibility of anaerobic bacteria, both to help the making of therapeutic decisions in individual cases and to improve the sampling of strains which have to be saved and sent to the centre doing periodic surveys of resistance patterns in anaerobes. Downloaded from at Pennsylvania State University on May, 06 Material and Methods In a general hospital of 900 beds, the study reveiwed anaerobic infections from which was isolated at least one anaerobic bacterium, in a two-year period from January //DO0O9 + 0 $0.00/0 9 9 The British Society for Antimicrobial Chemotherapy

2 0 J. F. Acar et al Table I. Estimation of susceptibility by inhibition zone diameter measurements. Antibiotics Ampicillin Cefoxitin Tetracycline Clindamycin Chloramphenicol Metronidazolc Disc content G*g) Susceptible > 7mm > mm > 6mm > mm > mm > 0mm to December 90. The procedure of isolation was based on plating the suspected specimen on Columbia ANC-blood agar, Chocolate Isovitalex agar and B.H.I, agar supplemented with vitamin K, ( mg/) Isovitalex (%), vancomycin (0 mg/) and kanamycin (0 mg/). The plates were incubated h in Gas Pak jars at 7 C. Identification was mainly performed by API 0 ANA. The antibiotic susceptibility testing was performed by the single disc method on Mueller Hinton agar with % horse blood and vitamin K, ( mg/). Suspensions of colonies taken from the plates were adjusted to the turbidity of No. MacFarland standard giving cfu/ml. The inoculum was applied by flooding the agar plates. Zones of inhibition were measured after h incubation in Gas Pak jars. The antibiotics tested and the interpretation of susceptibility are summarized on Table I. Bacteroides fragilis and clostridia could be easily tested by this method. Agar dilution tests were performed by incorporating serial twofold dilutions of the antibiotics in Mueller-Hinton agar with % horse blood and vitamin K, ( mg/). The inoculum was applied by means of a Steers replicator, yielding 0* cfu/spot. The Minimum Inhibitory Concentration (MIC) was determined after -h incubation in Gas Pak jars. The agar dilution test was applied to organisms exhibiting an unusual pattern of resistance on disc testing and to organisms isolated from severe or poorly-controlled infections. The antibiotics tested and the critical MIC for considering a strain resistant were as follows: ampicillin (^ mg/), carbenicillin (^ mg/), cefoxitin (;> mg/), moxalactam (^ mg/), thienamycin (^ mg/), chloramphenicol (> 6 mg/), tetracycline (S; mg/), metronidazole (>mg/l), clindamycin (^ mg/). Downloaded from at Pennsylvania State University on May, 06 Results The specific identification of the 77 bacteria used in this study is given in Table II. Gram-positive cocci include peptococci and peptostreptocci. Table III gives the origin of the strains studied: the 77 strains were isolated from 9 patients. The overall proportion of B. fragilis, Bacteroides sp. and clostridia resistant to the antibiotics tested by disc method is given in Table IV. Seventy-five per cent of the B. fragilis resistant to clindamycin were also resistant to tetracycline. Tables V to VII summarize the results of MIC determinations. Nine out of 7 Bacteroides spp. tested were resistant to clindamycin with MIC ^6 mg/, and strains were highly resistant to metronidazole with MIC;> mg/. The resistance pattern of the strains tested by MIC is given in Table VIII.

3 Resistance pattern of anaerobic bacteria Table n. Identification of the anaerobic species isolated Gram-negative bacilli Pus* Genital infections Blood cultures Pulmonary infections Miscellanous Total Bacteroides fragilis Other Bacteroides Bacteroides spp. Fusobacterium sp. Unidentified GNB Gram-positive bacilli Clostridium perfringens Clostridium difficile Actinomyces sp. Bifidobacterium sp. Propionibacterium sp. Other bacilli Gram-positive cocci Table HI. Origin of the anaerobic bacteria Gram-negative Gram-positive Gram-positive bacilli bacilli cocci Total (9%) 'Including peritoneal drainage. 0 9 (6%) Discussion 76 9 (%) B. fragilis and clostndia can be easily isolated even in ill-equipped routine laboratories. Several studies have demonstrated that for these rapidly growing bacteria, the prediction of susceptibility based on zone diameter measurements is generally accurate. (Wilkins et al, 97; Sutter, Kwok & Finegold, 97; Kwok et al, 97). However, this method may overestimate resistance to some antibiotics if the media, the inoculum and the incubation conditions are not carefully respected (Rahimi, Martin & Washington, 97). This concerns especially metronidazole and clindamycin. With a too heavy inoculum or when the anaerobic conditions are not satisfactory, growth of anaerobic bacteria may still occur but a sharp decrease of the inhibition zone around the metronidazole disc will be observed. If the concentration of CO, is too high, as often observed in the Gas Pak jars there may be a decrease in the ph of unbuffered media which also results in a decrease of the inhibition zone around the clindamycin disc, as reported for other macrolides (Ingham et al, 970). A too low disc content, as in the Downloaded from at Pennsylvania State University on May, 06

4 Table IV. Resistance of anaerobic bacteria to antibiotics when tested by the disc method. No. of isolates Ampicillin Cefoxitin % Isolates iresistant to Chloramphenicol Tetracycline Clindamycin Metronidazole Bacteroides fragilis Bacteroides sp. Clostridium perfringens

5 Resistance pattern of anaerobic bacteria Table V. MICs for strains of Bacteroides fragilis Number of isolates with MIC 6 (rag/) of 6 :6 Ampicillin Carbenicillin Cefoxitin Moxalactam Thienamycin Chloramphenicol Tetracycline Clindamycin Metronidazote npicillin irbcnicillin :foxitin oxalactam lienamycin lloramphenicol itracycline indamycin etronidazole 00 6 TaWe VI. MICs for strains of Bacteroides sp. Number of isolates with MIC (mg/) of Table VII. MICs for 0 strains of Clostridium sp. 6 6 >6 Downloaded from at Pennsylvania State University on May, Number of isolates with MIC (mg/) of: jnpicillin 'arbenicillin efoxitin foxalactam hienamycin 7 Woramphenicol etracycline lindamycin letronidazole

6 Table VHI. Resistance pattern of anaerobes tested by agar dilution method. o a -a a. S u e g III II <U S P u H u S. fragilis + + B. fragilis + + B. fragilis fi. fragilis fragilis B. fragilis B. fragilis B. fragilis B. fragilis B. fragilis B. fragilis B. fragilis B. fragilis B. distasonis + + B. distasonis B. distasonis Bacteroides sp. + + Bacteroides sp Cl. perfringens + + Cl. perfringens + + tp://jac.oxfordjournals.org/ at Pennsylvania State University on May, 06

7 Resistance pattern of anaerobic bacteria fig clindamycin disc, may also result in false reports of resistant strains. Thus, suspected resistance to these antibiotics must always be checked by agar dilution methods in presence of control strains with known MIC (Sutter et al., 979). In our study, about % of the bacteroides are resistant to mg/ of metronidazole, which is higher than some previous reports from France and U.S.A. (Sutter & Finegold, 976; Henderson, Chow & Guze, 977; Dubois el al., 97; Tytgat 90; Dublanchet & Durieux, 90). In South Africa, % of B. fragilis have been reported resistant to 6 mg/ metronidazole (Appelbaum & Chatterton, 97). In another U.S. report, 7% of the Bacteroides sp. studied were resistant to 00 mg/ metronidazole (Chow et al., 97). However, it must be emphasized that these findings do not appear to have been independently corroborated. The widespread use of metronidazole as a therapeutic and prophylactic agent in some areas may explain some of these discrepancies. Resistance to clindamycin was uncommon a few years ago and remains low even in recent reports (Sutter & Finegold, 976; Appelbaum & Chatterton 97; Kwok et al., 979; Tytgat, 90; Brown & Waati, 90). The high level of 0% clindamycin-resistant Bacteroides encountered in this study cannot be easily explained: when tested by agar dilution methods, 9 out 7 Bacteroides sp. were resistant to more than 6 mg/ clindamycin. Streptogramin antibiotics, not used elsewhere, are widely used in France in animal and human infections. These antibiotics are able to select strains resistant to macrolides and clindamycin. Finally, the incidence of plasmid-mediated clindamycin resistance has to be monitored (Privitera et al., 979). Results for the other antibiotics are in agreement with the findings in previous studies. Almost all the B. fragilis are resistant to ampicillin. More than 60% of Clostridium sp. and 70% of Bacteroides sp. are resistant to tetracycline. In contrast, all the Clostridium sp. were sensitive to penicillins and cephalosoporins. Resistance of Bacteroides sp. to cefoxitin and moxalactam is still rare, and resistance to chloramphenicol is very uncommon. Of special interest are strains exhibiting joint resistance to the clinically most useful antibiotics cefoxitin, clindamycin and metronidazole. In our survey, % of the Bacteroides sp. are resistant to at least of these antibiotics. One strain of Bacteroides distasonis isolated from a blood culture was resistant to all the antibiotics tested. Antibiotic resistant anaerobic bacteria are encountered with an increasing frequency but with few exceptions the percentage of resistant strains is still moderate and in most cases at least two major products remain effective. However, periodic surveys should be done regularly to detect and to follow the spread of anaerobic bacteria resistant to antibiotics. Downloaded from at Pennsylvania State University on May, 06 References Appelbaum, P. C. & Chatterton, S. A. (97). Susceptibility of anaerobic bacteria to ten antimicrobial agents. Antimicrobial Agents and Chemotherapy, 7-6. Brown, W. J. & Waati, P. E. (90). Susceptibility testing of clinically isolated anaerobic bacteria by an agar dilution technique. Antimicrobial Agents and Chemotherapy 7, 69-. Chow, A. W., Patten, V. & Guze, L. B. (97). Susceptibility of anaerobic bacteria to metronidazole: relative resistance of non-spore-forming gram positive bacilli. Journal of Infectious Diseases, -. Dublanchet, A. & Durieux, R. (90). Sensibilite comparee in vitro de quelques bacteries aerobics et anaerobies a trois derives des -nitro-imidazoles: le metronidazole, l'ornidazole et le tinidazole. Annales de Microbiologie A, -9.

8 6 J. F. Acar et al. Dubois, J., Pechere, J. C. & Turgeon, P. (97). Activity of ten antimicrobial agents against anaerobic bacteria. Journal of Antimicrobial Chemotherapy., 9-. Henderson, D. K., Chow, A. W. & Guze, L. B. (977). Comparative susceptibility of anaerobic bacteria to ticarcillin, cefoxitin metronidazole and related antimicrobial agents. Antimicrobial Agents and Chemotherapy, Ingham, H. R., Selkon, J. B., Codd, A. A. & Hale, J. H. (970). The effect of carbon dioxide on the sensitivity of Bacteroides fragilis to certain antibiotics in vitro. Journal of Clinical Pathology, -. King, A., Warren, C, Shannon, K. & Phillips, I. (90). The in-vitro antibacterial activity of cefotaxime compared with that of cefuroxime and cefoxitin. Journal of Antimicrobial Chemotherapy 6, 79-. Kislak, J. W. (97). The susceptibility of Bacteroides fragilis to antibiotics. Journal of Infectious Diseases, 9-9. Kwok, Y. Y., Tally, F. P., Sutter, V. L. & Finegold, S. M. (97). Disc susceptibility testing of slow-growing anaerobic bacteria. Antimicrobial Agents and Chemotherapy 7, -7. Percival, A. & Cumberland, N. (97). Antimicrobial susceptibilities of Gram-negative anaerobes. Journal of Antimicrobial Chemotherapy, Suppl. C, -. Phillips, I. (97). Antibiotic sensitivity of non-sporing anaerobes. In Infection with Non-sporing Anaerobic Bacteria (Phillips, I. & Sussman, M., Eds). Churchill Livingstone, Edinburgh, London & New York. Privitera, G., Dublanchet, A. & Sebald, M. (979). Transfer of multiple antibiotic resistance between subspecies of Bacteriodes fragilis. Journal of Infectious Diseases 9, Rahimi, A., Martin, W. J. & Washington, II J. A. (97). Effect of medium and inoculum on antimicrobial susceptibility of anaerobic bacteria. American Journal of Clinical Pathology 6, -7. Soussy, C. J., Thibault, M. & Duval, J. (9). Activite antibacterienne in vitro du cefotaxime sur les bacteries anaerobies. La Nouvelle Presse Medicate 0, 6-. Sutter, V. L., Kwok, Y. Y. & Finegold, S. M. (97). Susceptibility of Bacteroides fragilis to 6 antibiotics determined by standardized antimicrobial disc susceptibility testing. Antimicrobial Agents and Chemotherapy, -9. Sutter, V. L. & Finegold, S. M. (976). Susceptibility of anaerobic bacteria to antimicrobial agents. Antimicrobial Agents and Chemotherapy 0, Sutter, V. L., Oberhammer, I., Kwok, Y. Y. & Finegold, S. M. (97). Susceptibility of anaerobes to cefoxitin and cephalotin. Journal of Antimicrobial Chemotherapy, -6. Sutter, V. L., Barry, A. L., Wilkins, T. D. & Zabransky, R. J. (979). Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria. Antimicrobial Agents and Chemotherapy 6, 9-0. Tytgat, F. (90). Activite de sept antibiotiques sur Bacteroides fragilis. Annules de Microbiologie (lnstitut Pasteur), A: 9-. Wilkins, T. D., Holdeman, L. V., Abramson, I. J. & Moore, W. E. C. (97). Standardized singledisc method for antibiotic susceptibility testing of anaerobic bacteria. Antimicrobial Agents and Chemotherapy, -9. Downloaded from at Pennsylvania State University on May, 06

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to

More information

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION VIRBAC CORPORATION USA Product Label http://www.vetdepot.com P.O. BOX 162059, FORT WORTH, TX, 76161 Telephone: 817-831-5030 Order Desk: 800-338-3659 Fax: 817-831-8327 Website: www.virbacvet.com CLINTABS

More information

RELIABLE AND REALISTIC APPROACH TO SENSITIVITY TESTING

RELIABLE AND REALISTIC APPROACH TO SENSITIVITY TESTING RELIABLE AND REALISTIC APPROACH TO SENSITIVITY TESTING Pages with reference to book, From 94 To 97 S. Hafiz, N. Lyall, S. Punjwani, Shahida Q. Zaidi ( Department of Microbiology, The Aga Khan University

More information

Effects of Minocycline and Other Antibiotics on Fusobacterium necrophorum Infections in Mice

Effects of Minocycline and Other Antibiotics on Fusobacterium necrophorum Infections in Mice ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 1975, p. 421-425 Copyright 0 1975 American Society for Microbiology Vol. 7, No. 4 Printed in U.S.A. Effects of Minocycline and Other s on Fusobacterium necrophorum

More information

Susceptibility of Respiratory Tract Anaerobes to Orally Administered Penicillins and Cephalosporins

Susceptibility of Respiratory Tract Anaerobes to Orally Administered Penicillins and Cephalosporins ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 1976, p. 713-720 Copyright 0 1976 American Society for Microbiology Vol. 10, No. 4 Printed in U.S.A. Susceptibility of Respiratory Tract Anaerobes to Orally

More information

Christiane Gaudreau* and Huguette Gilbert

Christiane Gaudreau* and Huguette Gilbert Journal of Antimicrobial Chemotherapy (1997) 39, 707 712 JAC Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter

More information

EUCAST-and CLSI potency NEO-SENSITABS

EUCAST-and CLSI potency NEO-SENSITABS EUCASTand CLSI potency NEOSENSITABS Neo Sensitabs Page 1 / 6 Document: 6.2.0 Fastidious organisms EUCAST Interpretation zones and MIC breakpoints according to recommendations by the "Comité de l'antibiogramme

More information

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015 Aberdeen Hospital Antibiotic Susceptibility Patterns For Commonly Isolated s For 2015 Services Laboratory Microbiology Department Aberdeen Hospital Nova Scotia Health Authority 835 East River Road New

More information

SAMPLE. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals

SAMPLE. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals VET01 5th Edition Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals This standard covers the current recommended methods for disk diffusion

More information

Susceptibility Testing of Anaerobic Bacteria: Evaluation of the Redesigned (Version 96) biomérieux ATB ANA Device

Susceptibility Testing of Anaerobic Bacteria: Evaluation of the Redesigned (Version 96) biomérieux ATB ANA Device JOURNAL OF CLINICAL MICROBIOLOGY, June 1999, p. 1824 1828 Vol. 37, No. 6 0095-1137/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Susceptibility Testing of Anaerobic

More information

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER University of Minnesota Health University of Minnesota Medical Center University of Minnesota Masonic Children s Hospital May 2017 Printed herein are

More information

SESSION XVI NEW ANTIBIOTICS

SESSION XVI NEW ANTIBIOTICS SESSION XVI NEW ANTIBIOTICS New Antibiotics to Treat Anaerobic Infections 2 Goldstein, E.J.C.;* Citron, D.M. Antibiotic Pharmacodynamics 3 Stein, G.E.* Targeting Selenium Metabolism in Stickland Fermentors:

More information

APPENDIX III - DOUBLE DISK TEST FOR ESBL

APPENDIX III - DOUBLE DISK TEST FOR ESBL Policy # MI\ANTI\04\03\v03 Page 1 of 5 Section: Antimicrobial Susceptibility Testing Manual Subject Title: Appendix III - Double Disk Test for ESBL Issued by: LABORATORY MANAGER Original Date: January

More information

Susceptibility of the Bacteroides fragilis Group in the United

Susceptibility of the Bacteroides fragilis Group in the United ANTIMICROBIAL AGENTS AND CHEMOTHERPY, Apr. 1983, p. 536-540 0066-4804/83/040536-05$02.0O/0 Copyright C 1983, American Society for Microbiology Vol. 23, No. 4 Susceptibility of the Bacteroides fragilis

More information

Quality assurance of antimicrobial susceptibility testing

Quality assurance of antimicrobial susceptibility testing Quality assurance of antimicrobial susceptibility testing Derek Brown Routine quality control Repeated testing of controls in parallel with tests to ensure that the test system is performing reproducibly

More information

Chapter 2. Disk diffusion method

Chapter 2. Disk diffusion method Chapter 2. Disk diffusion method Tendencia, Eleonor A. Date published: 2004 To cite this document : Tendencia, E. A. (2004). Chapter 2. Disk diffusion method. In Laboratory manual of standardized methods

More information

Bacteria Isolated from Clinical Specimens1

Bacteria Isolated from Clinical Specimens1 ANTMCROBAL AGENT AND CHEMOTHERAPY, Feb., p. 8-8 Copyright American ociety for Microbiology Vol., No. Printed in U..A. n Vitro Antimicrobial usceptibility of Anaerobic Bacteria solated from Clinical pecimens

More information

Determination of antibiotic sensitivities by the

Determination of antibiotic sensitivities by the Journal of Clinical Pathology, 1978, 31, 531-535 Determination of antibiotic sensitivities by the Sensititre system IAN PHILLIPS, CHRISTINE WARREN, AND PAMELA M. WATERWORTH From the Department of Microbiology,

More information

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production

More information

Should we test Clostridium difficile for antimicrobial resistance? by author

Should we test Clostridium difficile for antimicrobial resistance? by author Should we test Clostridium difficile for antimicrobial resistance? Paola Mastrantonio Department of Infectious Diseases Istituto Superiore di Sanità, Rome,Italy Clostridium difficile infection (CDI) (first

More information

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants. Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants. C. difficile rarely causes problems, either in healthy adults or in infants.

More information

Performance Information. Vet use only

Performance Information. Vet use only Performance Information Vet use only Performance of plates read manually was measured in three sites. Each centre tested Enterobacteriaceae, streptococci, staphylococci and pseudomonas-like organisms.

More information

Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci

Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci Journal of Antimicrobial Chemotherapy (78) 4, 53-543 Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci Chatrchal Watanakunakoni and Cheryl Glotzbecker Infectious

More information

Drug resistance in relation to use of silver sulphadiazine cream in a burns unit

Drug resistance in relation to use of silver sulphadiazine cream in a burns unit J. clin. Path., 1977, 30, 160-164 Drug resistance in relation to use of silver sulphadiazine cream in a burns unit KIM BRIDGES AND E. J. L. LOWBURY From the MRC Industrial Injuries and Burns Unit, Birmingham

More information

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time) Key words I μ μ μ μ μ μ μ μ μ μ μ μ μ μ II Fig. 1. Microdilution plate. The dilution step of the antimicrobial agent is prepared in the -well microplate. Serial twofold dilution were prepared according

More information

Epidemiology and Antimicrobial Susceptibility of Anaerobic Bloodstream Infections: A 10 Years Study

Epidemiology and Antimicrobial Susceptibility of Anaerobic Bloodstream Infections: A 10 Years Study JMID/ 2018; 8 (4):135-139 Journal of Microbiology and Infectious Diseases doi: 10.5799/xxxxx RESEARCH ARTICLE Epidemiology and Antimicrobial Susceptibility of Anaerobic Bloodstream Infections: A 10 Years

More information

Principles and Practice of Antimicrobial Susceptibility Testing. Microbiology Technical Workshop 25 th September 2013

Principles and Practice of Antimicrobial Susceptibility Testing. Microbiology Technical Workshop 25 th September 2013 Principles and Practice of Antimicrobial Susceptibility Testing Microbiology Technical Workshop 25 th September 2013 Scope History Why Perform Antimicrobial Susceptibility Testing? How to Perform an Antimicrobial

More information

ANTI-ANAEROBIC ACTIVITIES OF SULOPENEM COMPARED TO SIX OTHER. Departments of Pathology, Hershey Medical Center, Hershey, PA 17033

ANTI-ANAEROBIC ACTIVITIES OF SULOPENEM COMPARED TO SIX OTHER. Departments of Pathology, Hershey Medical Center, Hershey, PA 17033 AAC Accepts, published online ahead of print on 17 February 2009 Antimicrob. Agents Chemother. doi:10.1128/aac.01557-08 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions.

More information

AAC Revised. Activity of a Novel Cyclic Lipopeptide, CB-183,315 Against Resistant Clostridium difficile

AAC Revised. Activity of a Novel Cyclic Lipopeptide, CB-183,315 Against Resistant Clostridium difficile AAC Accepts, published online ahead of print on 5 March 2012 Antimicrob. Agents Chemother. doi:10.1128/aac.06257-11 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 AAC06257-11

More information

Factors affecting plate assay of gentamicin

Factors affecting plate assay of gentamicin Journal of Antimicrobial Chemotherapy (1977) 3, 17-23 Factors affecting plate assay of gentamicin II. Media D. C. Shanson* and C. J. Hince Department of Medical Microbiology, The London Hospital Medical

More information

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method.

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. OBJECTIVES 1. Compare the antimicrobial capabilities of different antibiotics. 2. Compare effectiveness of with different types of bacteria.

More information

Ciprofloxacin, Enoxacin, and Ofloxacin against Aerobic and

Ciprofloxacin, Enoxacin, and Ofloxacin against Aerobic and ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1988, p. 1143-1148 Vol., No. 8 0066-4804/88/081143-06$00/0 Copyright 1988, American Society for Microbiology Comparative Activities of, Amoxicillin-Clavulanic

More information

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.

More information

January 2014 Vol. 34 No. 1

January 2014 Vol. 34 No. 1 January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton

More information

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2. AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony

More information

QUICK REFERENCE. Pseudomonas aeruginosa. (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.)

QUICK REFERENCE. Pseudomonas aeruginosa. (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.) Pseudomonas aeruginosa (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.) Description: Greenish gray colonies with some beta-hemolysis around each colony on blood agar (BAP),

More information

amoxycillin/clavulanate vs placebo in the prevention of infection after animal

amoxycillin/clavulanate vs placebo in the prevention of infection after animal Archives of Emergency Medicine, 1989, 6, 251-256 A comparative double blind study of amoxycillin/clavulanate vs placebo in the prevention of infection after animal bites P. H. BRAKENBURY & C. MUWANGA Accident

More information

J. W. Mouton, H. P. Endtz, J. G. den Hollander, N. van den Braak and H. A. Verbrugh

J. W. Mouton, H. P. Endtz, J. G. den Hollander, N. van den Braak and H. A. Verbrugh Journal of Antimicrobial Chemotherapy (1997) 39, Suppl. A, 75 80 JAC In-vitro activity of quinupristin/dalfopristin compared with other widely used antibiotics against strains isolated from patients with

More information

on February 12, 2018 by guest

on February 12, 2018 by guest AAC Accepted Manuscript Posted Online 12 February 2018 Antimicrob. Agents Chemother. doi:10.1128/aac.00047-18 Copyright 2018 Stapert et al. This is an open-access article distributed under the terms of

More information

Background and Plan of Analysis

Background and Plan of Analysis ENTEROCOCCI Background and Plan of Analysis UR-11 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony count, to perform the identification

More information

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Method and guidelines There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

More information

R-factor mediated trimethoprim resistance: result of two three-month clinical surveys

R-factor mediated trimethoprim resistance: result of two three-month clinical surveys Journal of Clinical Pathology, 1978, 31, 850-854 R-factor mediated trimethoprim resistance: result of two three-month clinical surveys S. G. B. AMYES1, A. M. EMMERSON2, AND J. T. SMITH3 From the 'Department

More information

Microbiology : antimicrobial drugs. Sheet 11. Ali abualhija

Microbiology : antimicrobial drugs. Sheet 11. Ali abualhija Microbiology : antimicrobial drugs Sheet 11 Ali abualhija return to our topic antimicrobial drugs, we have finished major group of antimicrobial drugs which associated with inhibition of protein synthesis

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The

More information

Antimicrobial Susceptibility Testing: The Basics

Antimicrobial Susceptibility Testing: The Basics Antimicrobial Susceptibility Testing: The Basics Susan E. Sharp, Ph.D., DABMM, FAAM Director, Airport Way Regional Laboratory Director, Regional Microbiology and Molecular Infectious Diseases Laboratories

More information

Anaerobic and microaerophilic gram-positive cocci Peptococcus species, Peptostreptococcus species, Microaerophilic streptococci

Anaerobic and microaerophilic gram-positive cocci Peptococcus species, Peptostreptococcus species, Microaerophilic streptococci CLINDACIN Composition Each capsule contains Clindamycin (as hydrochloride) 150 mg Capsule Action Clindamycin bind exclusively to the 50S subunit of bacterial ribosomes and suppress protein synthesis. Clindamycin

More information

Multicenter Study of In Vitro Susceptibility of the Bacteroides fragilis Group, 1995 to 1996, with Comparison of Resistance Trends from 1990 to 1996

Multicenter Study of In Vitro Susceptibility of the Bacteroides fragilis Group, 1995 to 1996, with Comparison of Resistance Trends from 1990 to 1996 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 1999, p. 2417 2422 Vol. 43, No. 10 0066-4804/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Multicenter Study of In Vitro

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Quality Assurance of antimicrobial susceptibility testing Derek Brown EUCAST Scientific Secretary ESCMID Postgraduate Education Course, Linz, 17 September 2014 Quality Assurance The total process by which

More information

Himani B. Pandya, Ph.D (medical microbiology) Tutor, S.B.K.S Medical College and Research Institute Gujarat, INDIA

Himani B. Pandya, Ph.D (medical microbiology) Tutor, S.B.K.S Medical College and Research Institute Gujarat, INDIA Prevalence and Microbiological diagnosis of Helicobacter pylori infection and it s antibiotic resistance pattern in the patients suffering from Acid-peptic Diseases Himani B. Pandya, Ph.D (medical microbiology)

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Reference Number: CP.HNMC.24 Effective Date: 07.01.17 Last Review Date: 02.18 Line of Business: Medicaid - HNMC Revision Log See Important Reminder at the end of this policy for important

More information

GeNei TM. Antibiotic Sensitivity. Teaching Kit Manual KT Revision No.: Bangalore Genei, 2007 Bangalore Genei, 2007

GeNei TM. Antibiotic Sensitivity. Teaching Kit Manual KT Revision No.: Bangalore Genei, 2007 Bangalore Genei, 2007 GeNei Bacterial Antibiotic Sensitivity Teaching Kit Manual Cat No. New Cat No. KT68 106333 Revision No.: 00180705 CONTENTS Page No. Objective 3 Principle 3 Kit Description 4 Materials Provided 5 Procedure

More information

Brief reports. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae

Brief reports. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae Journal of Antimicrobial Chemotherapy (1997) 40, 105 108 Brief reports JAC Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae Andreas Pikis a *, Jacob A. Donkersloot

More information

Patterns of Susceptibility to Fluoroquinolones Among Anaerobic Bacterial Isolates in the United States

Patterns of Susceptibility to Fluoroquinolones Among Anaerobic Bacterial Isolates in the United States S377 Patterns of Susceptibility to Fluoroquinolones Among Anaerobic Bacterial Isolates in the United States Ellie J. C. Goldstein From R. M. Alden Research Laboratory, Santa Monica Hospital Medical Center,

More information

Antimicrobial Resistance in Human Oral and Intestinal Anaerobic Microfloras

Antimicrobial Resistance in Human Oral and Intestinal Anaerobic Microfloras ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1993, p. 1665-1669 Vol. 37, No. 8 0066-4804/93/081665-05$02.00/0 Copyright X 1993, American Society for Microbiology Antimicrobial Resistance in Human Oral and

More information

Short Report. R Boot. Keywords: Bacteria, antimicrobial susceptibility testing, quality, diagnostic laboratories, proficiency testing

Short Report. R Boot. Keywords: Bacteria, antimicrobial susceptibility testing, quality, diagnostic laboratories, proficiency testing Short Report Frequent major errors in antimicrobial susceptibility testing of bacterial strains distributed under the Deutsches Krebsforschungszentrum Quality Assurance Program R Boot Former Section of

More information

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

PDF hosted at the Radboud Repository of the Radboud University Nijmegen PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/26062

More information

Secondary bacterial infections complicating skin lesions

Secondary bacterial infections complicating skin lesions J. Med. Microbiol. Vol. 51 (2002), 808 812 # 2002 Society for General Microbiology ISSN 0022-2615 REVIEW ARTICLE Secondary bacterial infections complicating skin lesions ITZHAK BROOK Department of Pediatrics,

More information

Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India

Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India ISSN: 2319-7706 Volume 4 Number 11 (2015) pp. 731-736 http://www.ijcmas.com Original Research Article Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching

More information

Quality Control Testing with the Disk Antibiotic Susceptibility Test of Bauer-Kirby-Sherris-Turck

Quality Control Testing with the Disk Antibiotic Susceptibility Test of Bauer-Kirby-Sherris-Turck Quality Control Testing with the Disk Antibiotic Susceptibility Test of Bauer-Kirby-Sherris-Turck DONNA J. BLAZEVIC, M.P.H., MARILYN H. KOEPCKE, B.S., A JOHN M. MATSEN, M.D. Departments of Laboratory Medicine

More information

Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents

Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents Journal of Antimicrobial Chemotherapy (2004) 53, 1039 1044 DOI: 10.1093/jac/dkh248 Advance Access publication 5 May 2004 Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic

More information

Mili Rani Saha and Sanya Tahmina Jhora. Department of Microbiology, Sir Salimullah Medical College, Mitford, Dhaka, Bangladesh

Mili Rani Saha and Sanya Tahmina Jhora. Department of Microbiology, Sir Salimullah Medical College, Mitford, Dhaka, Bangladesh Detection of extended spectrum beta-lactamase producing Gram-negative organisms: hospital prevalence and comparison of double disc synergy and E-test methods Mili Rani Saha and Sanya Tahmina Jhora Original

More information

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents Journal of Antimicrobial Chemotherapy (5) 35, -5 Brief reports Heat stability of the antimicrobial activity of sixty-two antibacterial agents Walter H. Traub and Birgit Leonhard Institut fur Medizinische

More information

against Clinical Isolates of Gram-Positive Bacteria

against Clinical Isolates of Gram-Positive Bacteria ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 366-370 Vol. 37, No. 0066-0/93/00366-05$0.00/0 Copyright 993, American Society for Microbiology In Vitro Activity of CP-99,9, a New Fluoroquinolone,

More information

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,

More information

PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 1996

PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 1996 PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 996 November 996 by Maggie Brett Antibiotic Reference Laboratory ESR Communicable Disease Centre Porirua CONTENTS Page SUMMARY

More information

Antimicrobials. Antimicrobials

Antimicrobials. Antimicrobials Antimicrobials For more than 50 years, antibiotics have come to the rescue by routinely producing rapid and long-lasting miracle cures. However, from the beginning antibiotics have selected for resistance

More information

Title: N-Acetylcysteine (NAC) Mediated Modulation of Bacterial Antibiotic

Title: N-Acetylcysteine (NAC) Mediated Modulation of Bacterial Antibiotic AAC Accepts, published online ahead of print on June 00 Antimicrob. Agents Chemother. doi:0./aac.0070-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

Comparison of antibiotic susceptibility results obtained with Adatab* and disc methods

Comparison of antibiotic susceptibility results obtained with Adatab* and disc methods J Clin Pathol 1984;37:159-165 Comparison of antibiotic susceptibility results obtained with Adatab* and disc methods JJS SNELL, MVS DANVERS, PS GARDNER From the Division of Microbiological Reagents and

More information

An evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage

An evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage Journal of Antimicrobial Chemotherapy (1991) 27, Suppl. C, 1-7 An evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage J. J. Muscato",

More information

NON-SPORING ANAEROBES

NON-SPORING ANAEROBES 36 NON-SPORING ANAEROBES 36.1 INTRODUCTION Anaerobic bacteria are widespread and very important. They do not require oxygen for growth, which is often toxic for them. They lack the enzymes superoxide dismutase,

More information

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information

More information

Int.J.Curr.Microbiol.App.Sci (2018) 7(8):

Int.J.Curr.Microbiol.App.Sci (2018) 7(8): International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 08 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.708.378

More information

Effect of Lactobacillus F19 on the emergence of antibioticresistant microorganisms in the intestinal microflora

Effect of Lactobacillus F19 on the emergence of antibioticresistant microorganisms in the intestinal microflora Journal of Antimicrobial Chemotherapy (2004) 54, 791 797 DOI: 10.1093/jac/dkh406 Advance Access publication 25 August 2004 Effect of Lactobacillus F19 on the emergence of antibioticresistant microorganisms

More information

Synergism Between Penicillin, Clindamycin, or Metronidazole and Gentamicin Against Species of the Bacteroides melaninogenicus and

Synergism Between Penicillin, Clindamycin, or Metronidazole and Gentamicin Against Species of the Bacteroides melaninogenicus and ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 1984, p. 71-77 0066-4804/84/010071-07$02.00/0 Copyright C 1984, American Society for Microbiology Vol. 25, No. 1 Synergism Between Penicillin, Clindamycin, or

More information

Present Status of Therapy for Anaerobic Infections

Present Status of Therapy for Anaerobic Infections 89 Present Status of Therapy for Anaerobic Infections Sydney M. Finegold and Hannah M. Wexler From the Medical and Research Services, Veterans Affairs Medical Center West Los Angeles, and the Department

More information

Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli. CRL Training course in AST Copenhagen, Denmark 23-27th Feb.

Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli. CRL Training course in AST Copenhagen, Denmark 23-27th Feb. Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli CRL Training course in AST Copenhagen, Denmark 23-27th Feb. 2009 Methodologies E-test by AB-biodisk A dilution test based on the

More information

In Vitro Activity of Netilmicin, Gentamicin, and Amikacin

In Vitro Activity of Netilmicin, Gentamicin, and Amikacin ANTIMICROBIAL AGzNTS AND CHEMOTHERAPY, Jan. 1977, p. 126-131 Copyright X 1977 American Society for Microbiology Vol. 11, No. 1 Printed in U.S.A. In Vitro Activity of Netilmicin, Gentamicin, and Amikacin

More information

What s new in EUCAST methods?

What s new in EUCAST methods? What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests

More information

Antibacterial susceptibility testing

Antibacterial susceptibility testing Antibiotics: Antil susceptibility testing are natural chemical substances produced by certain groups of microorganisms (fungi, ) that inhibit the growth of or kill the other that cause infection. Several

More information

Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran

Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran Letter to the Editor Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran Mohammad Rahbar, PhD; Massoud Hajia, PhD

More information

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria

More information

BACTERIOLOGY OF THE HEALTHY CONJUNCTIVA*

BACTERIOLOGY OF THE HEALTHY CONJUNCTIVA* Brit. J. Ophthal. (1954), 38, 719. BACTERIOLOGY OF THE HEALTHY CONJUNCTIVA* BY C. H. SMITH Department of Pathology, Institute of Ophthalmology, University of London THE normal bacterial flora of the mucous

More information

VLLM0421c Medical Microbiology I, practical sessions. Protocol to topic J05

VLLM0421c Medical Microbiology I, practical sessions. Protocol to topic J05 Topic J05: Determination of susceptibility of bacteria to antimicrobial drugs, assessments of resistance factors For study: textbooks, www, keywords e. g. Diffusion disc test ; E-test ; dilution micromethod

More information

A study in vitro of the sensitivity to antibiotics of Bacteroides fragilis

A study in vitro of the sensitivity to antibiotics of Bacteroides fragilis J. clin. Path. (198), 1, - A study in vitro of the sensitivity to antibiotics of Bacteroides fragilis H. R. INGHAM, J. B. SELKON, A. A. CODD, AND J. H. HALE From the Regional Public Health Laboratory,

More information

CLSI vs. EUCAST. What is EUCAST? Structure of EUCAST CLSI. Where they fit? SASCM WORKSHOP 5/24/2014

CLSI vs. EUCAST. What is EUCAST? Structure of EUCAST CLSI. Where they fit? SASCM WORKSHOP 5/24/2014 vs. Olga Perovic, Principal Pathologist, Center for Opportunistic, Tropical and Hospital Infections, Associate Professor at WITS, Saturday, May 24, 2014 A not-for-profit membership organization, the Clinical

More information

General Infectious Disease Concepts/Resources

General Infectious Disease Concepts/Resources General Infectious Disease Concepts/Resources Learning Objectives: 1. Distinguish between foundational infectious disease concepts including gram positive and negative bacteria, bacteriostatic and bactericidal

More information

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017 Antibiotics Antimicrobial Drugs Chapter 20 BIO 220 Antibiotics are compounds produced by fungi or bacteria that inhibit or kill competing microbial species Antimicrobial drugs must display selective toxicity,

More information

Macrolide-Lincosamide-Streptogramin Resistance Patterns in

Macrolide-Lincosamide-Streptogramin Resistance Patterns in ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 1981, p. 274-278 0066-4804/81/020274-05$02.00/0 Vol. 19, No. 2 Macrolide-Lincosamide-Streptogramin Resistance Patterns in Clostridium perfringens from Animals

More information

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic

More information

January 2014 Vol. 34 No. 1

January 2014 Vol. 34 No. 1 January 2014 Vol. 34 No. 1. and Minimal Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) roth dilution: cation-adjusted Mueller-Hinton

More information

Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli

Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli CRL Campylobacter Workshop The 7th -8th of Oct. 2008 National Veterinary Institute Uppsala, Sweden Legislation The Commission has

More information

EUCAST recommended strains for internal quality control

EUCAST recommended strains for internal quality control EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC

More information

56 Clinical and Laboratory Standards Institute. All rights reserved.

56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C 56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C. Zone Diameter and Minimal Inhibitory Concentration Breakpoints for Testing Conditions Medium: Inoculum: diffusion:

More information

by adding different antibiotics to sera containing

by adding different antibiotics to sera containing J. clin. Path., 1977, 30, 521-525 Serum gentamicin assays of 100 clinical serum samples by a rapid 40 C Kiebsiella method compared with overnight plate diffusion and acetyltransferase assays D. C. SHANSONI

More information

Prevalence of Extended Spectrum Beta- Lactamase Producers among Various Clinical Samples in a Tertiary Care Hospital: Kurnool District, India

Prevalence of Extended Spectrum Beta- Lactamase Producers among Various Clinical Samples in a Tertiary Care Hospital: Kurnool District, India International Journal of Current Microbiology and Applied Sciences ISSN: 319-77 Volume Number (17) pp. 57-3 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/1.5/ijcmas.17..31

More information

Defining Resistance and Susceptibility: What S, I, and R Mean to You

Defining Resistance and Susceptibility: What S, I, and R Mean to You Defining Resistance and Susceptibility: What S, I, and R Mean to You Michael D. Apley, DVM, PhD, DACVCP Department of Clinical Sciences College of Veterinary Medicine Kansas State University Susceptible

More information

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical

More information

Version 1.01 (01/10/2016)

Version 1.01 (01/10/2016) CHN58: ANTIMICROBIAL SUSCEPTIBILITY TESTING (CLSI) 1.0 PURPOSE / INTRODUCTION: 1.1 Introduction Antimicrobial susceptibility tests are performed in order to determine whether a pathogen is likely to be

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01

More information

Anaerobe bakterier og resistens. Ulrik Stenz Justesen Klinisk Mikrobiologisk Afdeling Odense Universitetshospital Odense, Denmark

Anaerobe bakterier og resistens. Ulrik Stenz Justesen Klinisk Mikrobiologisk Afdeling Odense Universitetshospital Odense, Denmark Anaerobe bakterier og resistens Ulrik Stenz Justesen Klinisk Mikrobiologisk Afdeling Odense Universitetshospital Odense, Denmark Programme anaerobic bacteria Carbapenem and metronidazole resistance New

More information